Gaush Meditech Ltd (HKG:2407)

Gaush Meditech Statistics

Total Valuation

Gaush Meditech has a market cap or net worth of HKD 755.70 million. The enterprise value is 843.00 million.

Market Cap	755.70M
Enterprise Value	843.00M

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Gaush Meditech has 145.33 million shares outstanding. The number of shares has decreased by -1.83% in one year.

Current Share Class	145.33M
Shares Outstanding	145.33M
Shares Change (YoY)	-1.83%
Shares Change (QoQ)	-1.21%
Owned by Insiders (%)	44.51%
Owned by Institutions (%)	0.29%
Float	50.06M

Valuation Ratios

The trailing PE ratio is 7.05.

PE Ratio	7.05
Forward PE	n/a
PS Ratio	0.49
PB Ratio	0.40
P/TBV Ratio	1.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.88
EV / Sales	0.55
EV / EBITDA	4.46
EV / EBIT	6.73
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.30.

Current Ratio	2.40
Quick Ratio	1.33
Debt / Equity	0.30
Debt / EBITDA	2.99
Debt / FCF	n/a
Interest Coverage	5.75

Financial Efficiency

Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 5.07%.

Return on Equity (ROE)	5.55%
Return on Assets (ROA)	2.71%
Return on Invested Capital (ROIC)	5.07%
Return on Capital Employed (ROCE)	5.18%
Weighted Average Cost of Capital (WACC)	3.81%
Revenue Per Employee	1.72M
Profits Per Employee	119,866
Employee Count	893
Asset Turnover	0.53
Inventory Turnover	2.20

Taxes

In the past 12 months, Gaush Meditech has paid 26.14 million in taxes.

Income Tax	26.14M
Effective Tax Rate	20.48%

Stock Price Statistics

The stock price has increased by +0.78% in the last 52 weeks. The beta is 0.02, so Gaush Meditech's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	+0.78%
50-Day Moving Average	5.97
200-Day Moving Average	7.67
Relative Strength Index (RSI)	42.49
Average Volume (20 Days)	89,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gaush Meditech had revenue of HKD 1.54 billion and earned 107.04 million in profits. Earnings per share was 0.74.

Revenue	1.54B
Gross Profit	704.63M
Operating Income	125.31M
Pretax Income	127.62M
Net Income	107.04M
EBITDA	188.85M
EBIT	125.31M
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 487.03 million in cash and 564.36 million in debt, with a net cash position of -77.33 million or -0.53 per share.

Cash & Cash Equivalents	487.03M
Total Debt	564.36M
Net Cash	-77.33M
Net Cash Per Share	-0.53
Equity (Book Value)	1.89B
Book Value Per Share	13.02
Working Capital	701.54M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	65.60M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 45.87%, with operating and profit margins of 8.16% and 6.97%.

Gross Margin	45.87%
Operating Margin	8.16%
Pretax Margin	8.31%
Profit Margin	6.97%
EBITDA Margin	12.29%
EBIT Margin	8.16%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 5.78%.

Dividend Per Share	0.30
Dividend Yield	5.78%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.83%
Shareholder Yield	7.61%
Earnings Yield	14.16%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3